| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |